| Active ingredient (INN) | Scopolamine |
|---|---|
| Brand names | Scopolamine Transdermal System |
| Therapeutic category | Auto-created by U.S. Food and Drug Administration — Drug Shortages scraper |
| Controlled substance | No |
|---|
| Marketing-authorisation holders | Mylan Pharmaceuticals Inc., PD-RX Pharmaceuticals, Inc., Padagis Israel Pharmaceuticals Ltd, INGENUS PHARMACEUTICALS, LLC +1 more |
|---|
| Registrations on file | 8 |
|---|
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Scopolamine | 1mg/3d | patch | 🇺🇸 US | Mylan Pharmaceuticals Inc. | Active |
| Methscopolamine Bromide | 2.5mg/1 | tablet | 🇺🇸 US | PD-RX Pharmaceuticals, Inc. | Active |
| Methscopolamine Bromide | 5mg/1 | tablet | 🇺🇸 US | PD-RX Pharmaceuticals, Inc. | Active |
| Scopolamine Transdermal System | 1mg/1 | patch | 🇺🇸 US | Padagis Israel Pharmaceuticals Ltd | Discontinued |
| Scopolamine | 1.5mg/1 | patch | 🇺🇸 US | INGENUS PHARMACEUTICALS, LLC | Active |
| Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide | .0194; .1037; 16.2; .0065mg/5mL; mg/5mL; mg/5mL; mg/5mL | elixir | 🇺🇸 US | INGENUS PHARMACEUTICALS, LLC | Active |
| Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate and Scopolamine Hydrobromide | .0194; .1037; 16.2; .0065mg/1; mg/1; mg/1; mg/1 | tablet | 🇺🇸 US | INGENUS PHARMACEUTICALS, LLC | Active |
| Scopolamine Trandermal System | 1mg/1 | patch | 🇺🇸 US | Bryant Ranch Prepack | Active |